CTOs on the Move

Humacyte

www.humacyte.com

 
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.humacyte.com
  • 2525 E NC Highway 54
    Durham, NC USA 27713
  • Phone: 919.313.9633

Executives

Name Title Contact Details
Heather Prichard
Chief Operating Officer Profile

Funding

Humacyte raised $150M on 10/20/2015
Humacyte raised $18M on 10/02/2017
Humacyte raised $150M on 06/11/2018
Humacyte raised $50M on 04/14/2021
Humacyte raised $38M on 04/14/2021

Similar Companies

CanReg

CanReg, Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Sibery Group

The Sibery Group LLC is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Porex Corporation

Porex Corporation is a Fairburn, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Suveto

Our vision is for all veterinary professionals to be empowered and equipped to take ownership of their professional growth, personal well-being and veterinary medicine.

Ernest Gallo Clinic and Research Center

Ernest Gallo Clinic and Research Center is a Emeryville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.